Back to top

Image: Bigstock

How Investors Can Grab Better Returns for Medical Using the Zacks ESP Screener

Read MoreHide Full Article

Two factors often determine stock prices in the long run: earnings and interest rates. Investors can't control the latter, but they can focus on a company's earnings results every quarter.

Life and the stock market are both about expectations, and rising above what is expected is often rewarded, while falling short can come with negative consequences. Investors might want to try to capture stronger returns by finding positive earnings surprises.

Hunting for 'earnings whispers' or companies poised to beat their quarterly earnings estimates is a somewhat common practice. But that doesn't make it easy. One way that has been proven to work is by using the Zacks Earnings ESP tool.

The Zacks Earnings ESP, Explained

The Zacks Earnings ESP is more formally known as the Expected Surprise Prediction, and it aims to grab the inside track on the latest analyst estimate revisions ahead of a company's report. The idea is relatively intuitive as a newer projection might be based on more complete information.

Now that we understand the basic idea, let's look at how the Expected Surprise Prediction works. The ESP is calculated by comparing the Most Accurate Estimate to the Zacks Consensus Estimate, with the percentage difference between the two giving us the Zacks ESP figure.

Bringing together a positive earnings ESP alongside a Zacks Rank #3 (Hold) or better has helped stocks report a positive earnings surprise 70% of the time. Furthermore, by using these parameters, investors have seen 28.3% annual returns on average, according to our 10 year backtest.

Stocks with a ranking of #3 (Hold), or 60% of all stocks covered by the Zacks Rank, are expected to perform in-line with the broader market. Stocks with rankings of #2 (Buy) and #1 (Strong Buy), or the top 15% and top 5% of stocks, respectively, should outperform the market; Strong Buy stocks should outperform more than any other rank.

Should You Consider UnitedHealth Group?

The final step today is to look at a stock that meets our ESP qualifications. UnitedHealth Group (UNH - Free Report) earns a #3 (Hold) 30 days from its next quarterly earnings release on October 13, 2022, and its Most Accurate Estimate comes in at $5.55 a share.

UNH has an Earnings ESP figure of +1.76%, which, as explained above, is calculated by taking the percentage difference between the $5.55 Most Accurate Estimate and the Zacks Consensus Estimate of $5.45. UnitedHealth Group is one of a large database of stocks with positive ESPs. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

UNH is just one of a large group of Medical stocks with a positive ESP figure. Eli Lilly (LLY - Free Report) is another qualifying stock you may want to consider.

Slated to report earnings on October 25, 2022, Eli Lilly holds a #3 (Hold) ranking on the Zacks Rank, and it's Most Accurate Estimate is $2.10 a share 42 days from its next quarterly update.

For Eli Lilly, the percentage difference between its Most Accurate Estimate and its Zacks Consensus Estimate of $1.94 is +7.9%.

UNH and LLY's positive ESP figures tell us that both stocks have a good chance at beating analyst expectations in their next earnings report.

Find Stocks to Buy or Sell Before They're Reported

Use the Zacks Earnings ESP Filter to turn up stocks with the highest probability of positively, or negatively, surprising to buy or sell before they're reported for profitable earnings season trading. Check it out here >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


UnitedHealth Group Incorporated (UNH) - free report >>

Eli Lilly and Company (LLY) - free report >>

Published in